目的 探究燈銀腦通膠囊聯(lián)合腦心通膠囊治療腦梗死恢復(fù)期的臨床療效。方法 選取2013年1月-2016年1月在天津中醫(yī)藥大學(xué)第一附屬醫(yī)院接受治療的腦梗死恢復(fù)期患者85例，隨機(jī)分為對照組（43例）和治療組（42例）。對照組口服腦心通膠囊，3粒/次，3次/d。治療組在對照組基礎(chǔ)上口服燈銀腦通膠囊，3粒/次，3次/d。兩組患者均治療3個(gè)月。觀察兩組的臨床療效，比較兩組的美國國立衛(wèi)生研究院卒中量表（NIHSS）評分、Barthel指數(shù)評分和生活質(zhì)量的情況。結(jié)果 治療后，對照組和治療組的總有效率分別為60.47%、80.95%，兩組比較差異有統(tǒng)計(jì)學(xué)意義（P<0.05）。治療后，兩組NIHSS評分均明顯降低，而Barthel指數(shù)評分均顯著升高，同組治療前后比較差異有統(tǒng)計(jì)學(xué)意義（P<0.05）；且治療組這些觀察指標(biāo)的改善程度明顯優(yōu)于對照組，兩組比較差異具有統(tǒng)計(jì)學(xué)意義（P<0.05）。治療后，兩組生理功能（PF）、生理職能（RP）、情感職能（RE）、社會功能（SF）、軀體疼痛（BP）、機(jī)體活力（VT）、精神健康（MH）和總體健康（GH）評分均顯著升高，同組治療前后比較差異有統(tǒng)計(jì)學(xué)意義（P<0.05）；且治療組這些觀察指標(biāo)的升高程度明顯優(yōu)于對照組，兩組比較差異具有統(tǒng)計(jì)學(xué)意義（P<0.05）。結(jié)論 燈銀腦通膠囊聯(lián)合腦心通膠囊治療腦梗死恢復(fù)期具有較好的臨床療效，能明顯改善神經(jīng)功能和生活能力，提高生活質(zhì)量，具有一定的臨床推廣應(yīng)用價(jià)值。

Objective To explore the clinical effect of Dengyin Naotong Capsules combined with Naoxintong Capsules in treatment of convalescence cerebral infarction. Methods Patients (85 cases) with convalescence cerebral infarction in First Teaching Hospital of Tianjin University of Traditional Chinese Medicine from January 2013 to January 2016 were randomly divided into control group (43 cases) and treatment group (42 cases). Patients in the control group were po administered with Naoxintong Capsules, 3 grains/time, three times daily. Patients in the treatment group were po administered with Dengyin Naotong Capsules on the basis of the control group, 3 grains/time, three times daily. Patients in two groups were treated for 3 months. After treatment, the clinical efficacies were evaluated, and NIHSS scores, Barthel index scores and quality of life in two groups were compared. Results After treatment, the clinical efficacies in the control and treatment groups were 60.47% and 80.95%, respectively, and there was difference between two groups (P<0.05). After treatment, NIHSS scores in two groups were significantly decreased, but Barthel index scores in two groups were significantly increased, and the difference was statistically significant in the same group (P<0.05). And the observational indexes in the treatment group were significantly better than those in the control group, with significant difference between two groups (P<0.05). After treatment, the scores of PF, RP, RE, SF, BP, VT, MH, and GH in two groups were significantly increased, and the difference was statistically significant in the same group (P<0.05). And the observational indexes in the treatment group were significantly higher than those in the control group, with significant difference between two groups (P<0.05). Conclusion Dengyin Naotong Capsules combined with Naoxintong Capsules has clinical curative effect in treatment of convalescence cerebral infarction, can significantly improve nerve function and life ability, and increase quality of life, which has a certain clinical application value.